Advertisement

Topics

Dosing Differences Opined for Costly Hemophilia Option

12:39 EDT 12 Jul 2019 | Medscape

Achieving the goal of zero bleeds as patients pursue active lives will require divergent dosing, according to PROPEL trial investigators who evaluated whether more exposure to FVIII improves outcomes.
Medscape Medical News

Original Article: Dosing Differences Opined for Costly Hemophilia Option

NEXT ARTICLE

More From BioPortfolio on "Dosing Differences Opined for Costly Hemophilia Option"

Advertisement
Quick Search
Advertisement
Advertisement